Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors (Q73181530)
Jump to navigation
Jump to search
scientific article published on 01 June 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors |
scientific article published on 01 June 1999 |
Statements
Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors (English)
V M Herben
J H Schellens
M Swart
G Gruia
L Vernillet
W W ten Bokkel Huinink